FDA goes af­ter web­sites mar­ket­ing 'u­nap­proved' semaglu­tide, tirzepatide

The FDA has is­sued warn­ings to two web­sites mar­ket­ing “re­search chem­i­cals” that pur­port­ed­ly con­tain semaglu­tide and tirzepatide, the ac­tive in­gre­di­ents be­hind No­vo Nordisk and Eli …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER